HK66888A - The use of melatonin for the manufacture of a medicament - Google Patents

The use of melatonin for the manufacture of a medicament

Info

Publication number
HK66888A
HK66888A HK668/88A HK66888A HK66888A HK 66888 A HK66888 A HK 66888A HK 668/88 A HK668/88 A HK 668/88A HK 66888 A HK66888 A HK 66888A HK 66888 A HK66888 A HK 66888A
Authority
HK
Hong Kong
Prior art keywords
melatonin
medicament
manufacture
Prior art date
Application number
HK668/88A
Other languages
English (en)
Inventor
Roger Valentine Short
Stuart Armstrong
Original Assignee
Univ Monash
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Monash filed Critical Univ Monash
Publication of HK66888A publication Critical patent/HK66888A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK668/88A 1983-05-18 1988-08-25 The use of melatonin for the manufacture of a medicament HK66888A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPF941883 1983-05-18
AUPG473484 1984-04-27

Publications (1)

Publication Number Publication Date
HK66888A true HK66888A (en) 1988-09-02

Family

ID=25642659

Family Applications (1)

Application Number Title Priority Date Filing Date
HK668/88A HK66888A (en) 1983-05-18 1988-08-25 The use of melatonin for the manufacture of a medicament

Country Status (4)

Country Link
US (1) US4665086A (xx)
EP (1) EP0126630B1 (xx)
DE (1) DE3466215D1 (xx)
HK (1) HK66888A (xx)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
US5629310A (en) * 1986-09-23 1997-05-13 Sterling; William R. Low dose temazepam
US5030632A (en) * 1986-09-23 1991-07-09 Sandoz Pharm. Corp. Low dose temazepam
US5211954A (en) * 1986-09-23 1993-05-18 Sandoz Ltd. Low dose temazepam
US5163426A (en) * 1987-06-26 1992-11-17 Brigham And Women's Hospital Assessment and modification of a subject's endogenous circadian cycle
US5167228A (en) * 1987-06-26 1992-12-01 Brigham And Women's Hospital Assessment and modification of endogenous circadian phase and amplitude
US5545192A (en) * 1987-06-26 1996-08-13 Brigham And Women's Hospital Intermittent use of bright light to modify the circadian phase
US5006985A (en) * 1988-07-15 1991-04-09 Kinetic Software, Inc. Computer system for minimizing body dysfunctions induced by jet travel or shift work
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
US5707652A (en) * 1990-12-04 1998-01-13 State Of Oregon Methods of treating circadian rhythm phase disorders
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
US5242941A (en) * 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders
US5591768A (en) * 1990-12-04 1997-01-07 State Of Oregan, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Methods for treating circadian rhythm phase disturbances
US5140562A (en) * 1991-03-13 1992-08-18 Moore Ede Martin C Biological timepiece
DE69229490T2 (de) * 1991-05-09 2000-02-17 Neurim Pharmaceuticals (1991) Ltd., Tel Aviv Melatonin enthaltende Arzneimittel
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
ZA928011B (en) * 1991-10-18 1993-06-23 Alza Corp Transdermal administration of melatonin.
IT1255199B (it) * 1992-07-01 1995-10-20 Franco Fraschini Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani
US5449683A (en) * 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
AU7550994A (en) * 1993-07-26 1995-02-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Sustained release oral compositions containing melatonin
US6180657B1 (en) 1993-11-18 2001-01-30 Eli Lilly And Company Melatonin derivatives for use in treating desynchronization disorders
US5654325A (en) * 1993-11-18 1997-08-05 Eli Lilly And Company Melatonin derivatives for use in treating sleep disorders
WO1997012612A1 (en) * 1995-10-03 1997-04-10 Interneuron Pharmaceuticals, Inc. Compositions of melatonin and analgetic agents and methods of use thereof
US6274615B1 (en) 1998-03-25 2001-08-14 South Alabama Medical Science Foundation Method for delaying the onset of alheimer's disease and for treatment or delaying the onset of other amyloidosis-related diseases/disorders
US6133453A (en) * 1998-05-15 2000-10-17 Pharm-Eco Laboratories, Inc. Method for making substituted indoles
IL144900A (en) * 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
US6703412B1 (en) * 2002-09-27 2004-03-09 Holly A. Rosenthal Method of treating sleeplessness with melatonin on an acute basis
EP2028937B2 (en) * 2006-05-22 2018-06-27 Vanda Pharmaceuticals Inc. Melatonin agonist treatment
CN101516255A (zh) * 2006-09-13 2009-08-26 皇家飞利浦电子股份有限公司 用于自动调整褪黑素的剂量和/或递送褪黑素的装置
WO2010012789A1 (en) * 2008-07-30 2010-02-04 Ferrer Internacional S. A. 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds
CA2753897A1 (en) * 2009-03-20 2010-09-23 The Salk Institute For Biological Studies Methods for modulating metabolic and circadian rhythms
JP2012521364A (ja) * 2009-03-20 2012-09-13 ザ ソーク インスティテュート フォー バイオロジカル スタディーズ 概日リズムを調整する方法
US8691275B2 (en) 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
BR112014018429A8 (pt) 2012-01-26 2017-07-11 Vanda Pharmaceuticals Inc Método para tratar um paciente que sofre de não-24, e, método para o tratamento crônico de não-24 em uma pessoa que está totalmente cega
AU2013361459A1 (en) 2012-12-18 2015-07-02 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders

Also Published As

Publication number Publication date
DE3466215D1 (en) 1987-10-22
EP0126630B1 (en) 1987-09-16
EP0126630A1 (en) 1984-11-28
US4665086A (en) 1987-05-12

Similar Documents

Publication Publication Date Title
DE3466215D1 (en) The use of melatonin for the manufacture of a medicament
GB8325529D0 (en) Medicinal forms
ZA848375B (en) Medicament formulation
EP0072251A3 (en) Improved bandage containing a medicament
AU90762S (en) Inhaler
GB8306666D0 (en) Therapeutic agents
GB8324313D0 (en) Anaesthetic vaporiseur
DE3369641D1 (en) Use of a benzoisothiazoline derivative for the manufacture of a medicament against thrombosis and platelet aggregation
DE3469898D1 (en) Therapeutic agents
GB2125803B (en) Medical casts
GB8419699D0 (en) Therapeutic table
GB8421574D0 (en) Monitoring use of medicines
PH20528A (en) 4-substituted-2-azetidinone compounds and medicaments containing the compounds
GB8315906D0 (en) Therapy helmet
ZA846174B (en) Therapeutic agents
GB8316632D0 (en) Administering medicaments
PT79679A (en) Process for the preparation of 2-thiocyanato-benzamides having a fungicidal effect
GB2162746B (en) Antiacidotic medicinal agent
GB8302666D0 (en) Drug convertarule
GB8334507D0 (en) Medicine
GB8305650D0 (en) Therapeutic agent
GB8311364D0 (en) Therapeutic agent
GB8321649D0 (en) Pharmaceutical use
GB8321648D0 (en) Pharmaceutical use
GB8321801D0 (en) Pharmaceutical use

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20040516

PE Patent expired